229 related articles for article (PubMed ID: 36167815)
21. Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians.
Tang Girdwood SC; Rossow KM; Van Driest SL; Ramsey LB
Pediatr Res; 2022 Feb; 91(3):529-538. PubMed ID: 33824446
[TBL] [Abstract][Full Text] [Related]
22. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
[TBL] [Abstract][Full Text] [Related]
23. Potentially actionable pharmacogenetic variants and symptom control medications in oncology.
Patel JN; Boselli D; Jandrisevits EJ; Hamadeh IS; Salem A; Meadors P; Walsh D
Support Care Cancer; 2021 Oct; 29(10):5927-5934. PubMed ID: 33758969
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients.
Lteif C; Eddy E; Terrell J; Cavallari LH; Malaty J; Duarte JD
Clin Transl Sci; 2024 Jan; 17(1):e13692. PubMed ID: 38013396
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenetic testing in psychiatric inpatients with polypharmacy is associated with decreased medication side effects but not via medication changes.
Collins AR; Kung S; Ho JT; Wright JA; Dammen KC; Johnson EK; Lapid MI; Leung JG
J Psychiatr Res; 2020 Jul; 126():105-111. PubMed ID: 32442780
[TBL] [Abstract][Full Text] [Related]
26. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
[TBL] [Abstract][Full Text] [Related]
27. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
[TBL] [Abstract][Full Text] [Related]
28. Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial.
Oslin DW; Chapman S; Duvall SL; Gelernter J; Ingram EP; Kranzler HR; Lehmann LS; Lynch JA; Lynch KG; Pyne JM; Shih MC; Stone A; Thase ME; Wray LO
Contemp Clin Trials; 2021 Feb; 101():106247. PubMed ID: 33316457
[TBL] [Abstract][Full Text] [Related]
29. Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice.
Soda T; Merner AR; Small BJ; Torgerson LN; Muñoz K; Austin J; Storch EA; Pereira S; Lázaro-Muñoz G
Psychiatry Res; 2023 Jul; 325():115246. PubMed ID: 37172398
[TBL] [Abstract][Full Text] [Related]
30. A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact.
Nunez-Torres R; Pita G; Peña-Chilet M; López-López D; Zamora J; Roldán G; Herráez B; Álvarez N; Alonso MR; Dopazo J; Gonzalez-Neira A
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111771
[TBL] [Abstract][Full Text] [Related]
31. Use of Pharmacogenetic Drugs by the Dutch Population.
Alshabeeb MA; Deneer VHM; Khan A; Asselbergs FW
Front Genet; 2019; 10():567. PubMed ID: 31312209
[TBL] [Abstract][Full Text] [Related]
32. Current status of the analytical validation of next generation sequencing applications for pharmacogenetic profiling.
Huebner T; Steffens M; Scholl C
Mol Biol Rep; 2023 Nov; 50(11):9587-9599. PubMed ID: 37787843
[TBL] [Abstract][Full Text] [Related]
33. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
[TBL] [Abstract][Full Text] [Related]
34. Interrogating Pharmacogenetics Using Next-Generation Sequencing.
Ji Y; Shaaban S
J Appl Lab Med; 2024 Jan; 9(1):50-60. PubMed ID: 38167765
[TBL] [Abstract][Full Text] [Related]
35. Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients.
Dong OM; Li A; Suzuki O; Oni-Orisan A; Gonzalez R; Stouffer GA; Lee CR; Wiltshire T
Pharmacogenomics; 2018 Jun; 19(9):771-782. PubMed ID: 29793377
[TBL] [Abstract][Full Text] [Related]
36. What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
Jameson A; Fylan B; Bristow GC; Sagoo GS; Dalton C; Cardno A; Sohal J; McLean SL
Front Genet; 2021; 12():740216. PubMed ID: 34630531
[TBL] [Abstract][Full Text] [Related]
37. Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS).
Bothos E; Ntoumou E; Kelaidoni K; Roukas D; Drakoulis N; Papasavva M; Karakostis FA; Moulos P; Karakostis K
J Transl Med; 2021 Apr; 19(1):151. PubMed ID: 33858454
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetic Testing in an Academic Psychiatric Clinic: A Retrospective Chart Review.
Brown L; Li J; Katel N; Yu K; Fatourou E; Himmler B; Halaris A
J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575674
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis.
Lenz C; Narang A; Bousman CA
Pharmacogenet Genomics; 2024 Jun; 34(4):130-134. PubMed ID: 38359167
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center.
Pasternak AL; Ward KM; Ateya MB; Choe HM; Thompson AN; Clark JS; Ellingrod V
J Pers Med; 2020 Oct; 10(4):. PubMed ID: 33023029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
